Results 61 to 70 of about 29,485 (183)

The m.14484T>C MT‐ND6 Mutation Presenting with a Hereditary Spastic‐Paraparesis Phenotype

Movement Disorders Clinical Practice, EarlyView.
Gabriel Amorelli, Christelle Nilles, Gerald Pfeffer, Matthew Joel, Davide Martino   +4 more
wiley   +1 more source

Relative frequency of Human T-cell Lymphotropic Virus I/II in HIV/AIDS patients

Advanced Biomedical Research, 2014
Background: Human T-cell lymphotropic virus HTLV-I/II is a retrovirus that has been associated with different diseases. HTLV-I/II routes of transmissions are exposure to contaminated blood, blood transfusion, needle sharing, breast feeding, and sexual ...
Mohsen Meidani, Nooshin Ahmadi, Bahareh Jamali, Zahra Askarian   +3 more
doaj   +1 more source

Prevalence of anti-HTLV-I & anti-HTLV-II antibodies in Blood donors in Bushehr Province

Iranian South Medical Journal, 2004
Human T-cll leukemia virus type 1 (HTLV-I) and HTLV-II are type C oncoviruses, members of the family Retroviridae. Blood transfusion is a transmission route. Screening for HTLV is routine in Khorasan Province/Iran.
Mahmood Reza Poukarim, Gholamreza Khamisipour, Keyvan Zandi, Mohammad Hasan Roustaee   +3 more
doaj  

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)

Retrovirology, 2008
Background HTLV-I is the causal agent of adult T cell leukemia (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Biomarkers are needed to diagnose and/or predict patients who are at risk for HAM/TSP or ATLL.
Mahieux Renaud, Janik John E, Oh Unsong, Yao Karen, Graham Jhanelle, Leahy Hannah P, Meoli Elise, Burbelo Peter D, Kashanchi Fatah, Iadarola Michael J, Jacobson Steven   +10 more
doaj   +1 more source

Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Oncogenic viral and bacterial infections constitute a significant portion of the global cancer burden, accounting for up to 15% of cases, particularly in low‐ and middle‐income countries. Prophylactic vaccination thus appears to be the most effective tool for preventing these preventable cancers, especially those linked to human papillomavirus
Christian Tague, Johan Domga, Ayesha Junaid, Okhesomi Rejoice Eshemokhai, Josias Kamgang Silatchom, Criss Koba Mjumbe   +5 more
wiley   +1 more source

Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis

Brazilian Journal of Medical and Biological Research, 2005
To evaluate the human T-cell lymphotropic virus type I (HTLV-I) proviral DNA load among asymptomatic HTLV-I-infected carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), real time PCR using TaqMan probes for the
P.A. Montanheiro, A.C. Penalva de Oliveira, M.P. Posada-Vergara, A.C. Milagres, C. Tauil, P.E. Marchiori, A.J.S. Duarte, J. Casseb   +7 more
doaj   +1 more source

Seroprevalencia de HTLV-I/II en hombres gays y trabajadoras sexuales de la Isla de Margarita, Venezuela HTLV-I/II seroprevalence among gay men and female sex workers from Margarita Island, Venezuela

Revista da Sociedade Brasileira de Medicina Tropical, 1998
Sabida la importante seroprevalencia en la Isla de Margarita para el HIV-1 nos propusimos conocer la seroprevalencia de HTLV-I/II en muestras de grupos epidemiologicamente importantes en su transmisión.
E. Castro de Batänjer, G. Echeverría de Pérez   +1 more
doaj   +1 more source

HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression

Molecular Cancer, 2010
Background Human T-cell leukemia virus type I (HTLV-I) has efficiently adapted to its host and establishes a persistent infection characterized by low levels of viral gene expression and slow proliferation of HTLV-I infected cells over decades.
Bai XueTao, Pancewicz Joanna, Baydoun Hicham H, Nicot Christophe   +3 more
doaj   +1 more source

Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Marllon Cindra Sant'Ana, Mariana Maschietto, Daniela Paz Leal, Ricardo de Santos de Oliveira, Mayara Ferreira Euzébio, Antonio Carlos dos Santos, Luciano Neder, Carlos Alberto Scrideli, Elvis Terci Valera   +8 more
wiley   +1 more source

Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar

Asian Journal of Transfusion Science, 2015
Background and Objectives: Human T-cell lymphotropic virus type-I (HTLV-I) infection is considered as a public health challenge in endemic areas. The virus is associated with severe diseases, such as adult T-cell leukemia/lymphoma, and HTLV-I-associated ...
Mahtab Maghsudlu, Hamidreza Safabakhsh, Parastoo Jamili   +2 more
doaj   +1 more source